Back to top
more

Humana (HUM)

(Delayed Data from NYSE)

$349.30 USD

349.30
1,583,481

-2.92 (-0.83%)

Updated May 24, 2024 04:00 PM ET

After-Market: $349.35 +0.05 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 27% (68 out of 250)

Industry: Medical - HMOs

Better trading starts here.

Brokerage Reports

Research for HUM

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

0 items in cart

Humana Inc. [HUM]

Reports for Purchase

Showing records 601 - 620 ( 661 total )

Company: Humana Inc.

Industry: Medical - HMOs

Record: 601

01/20/2012

Daily Note

Pages: 7

Continue to View HUM as Top Near & LT Pick; See 5% Margins Sustainable

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 602

01/11/2012

Company Report

Pages: 11

Price: 24.95

Company: Humana Inc.

Industry: Medical - HMOs

Record: 603

01/06/2012

Industry Report

Pages: 37

LIFE SCIENCES: 2012 Life Sciences and Healthcare Preview: Macro and Sector Trends; Catalysts; Top Picks

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 75.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 604

01/04/2012

Daily Note

Pages: 35

Healthcare Services - Managed Care -Expect Conservative First Time Guidance; HUM Top Pick for 2012

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 75.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 605

12/08/2011

Industry Report

Pages: 9

Survey Shows Larger-than-Anticipated Interest in Exchanges

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 606

12/05/2011

Industry Report

Pages: 10

WS Survey Shows Increasing Preference for MA Among Pre-Eligibles

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 607

11/11/2011

Industry Report

Pages: 5

LIFE SCIENCES -The Week Ahead in Life Sciences

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 10.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 608

11/11/2011

Company Report

Pages: 11

Price: 24.95

Company: Humana Inc.

Industry: Medical - HMOs

Record: 609

11/03/2011

Company Report

Pages: 5

Third Quarter Benefited from Strong Medicare Advantage Business and Favorable Prior Period Claims Adjustment

Provider: J.J.B. Hilliard, W.L. Lyons

Analyst: O'NEIL S

Price: 10.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 610

11/01/2011

Company Report

Pages: 13

Unavoidable LT Growth with Near-Term Upside Potential From MLR/M&A; Raising PT to $102

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 50.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 611

10/31/2011

Daily Note

Pages: 7

Initial 2012 Outlook Screens as Conservative on MLR and Enrollment; Reiterate Outperform Rating

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 612

10/12/2011

Industry Report

Pages: 5

Make Strides in Improving Medicare Star Ratings

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 10.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 613

10/10/2011

Daily Note

Pages: 33

Healthcare Services - Managed Care: 3Q11 Preview

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 75.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 614

10/10/2011

Company Report

Pages: 7

Raising Estimates Based on Higher MA Enrollment In Connection With 3Q11 Preview

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 615

09/28/2011

Industry Report

Pages: 4

Healthcare Services - Managed Care -Three of Four Commercial Pricing Surveys Show Cycle Peak; Next up Mercer in 1-2 Weeks

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 10.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 616

09/20/2011

Industry Report

Pages: 20

With Several Data Points Suggesting Pricing Cycle Turn, United in Best Position

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 50.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 617

09/06/2011

Company Report

Pages: 9

Price: 24.95

Company: Humana Inc.

Industry: Medical - HMOs

Record: 618

08/25/2011

Daily Note

Pages: 5

Acquires Arcadian, Could Add $0.11-$0.13 to 2012E

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 10.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 619

08/19/2011

Company Report

Pages: 4

2Q EPS Up 7% as Revenue Increases 8%

Provider: J.J.B. Hilliard, W.L. Lyons

Analyst: O'NEIL S

Price: 10.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 620

08/02/2011

Company Report

Pages: 8

Price: 24.95